Shares of Omnicell Inc. (NASDAQ:OMCL) were up 1.9% during mid-day trading on Thursday . The company traded as high as $38.34 and last traded at $38.30, with a volume of 74,063 shares trading hands. The stock had previously closed at $37.58.

A number of analysts recently issued reports on OMCL shares. FBR & Co boosted their price objective on Omnicell from $35.00 to $40.00 and gave the company an “outperform” rating in a research note on Thursday, July 7th. Zacks Investment Research upgraded Omnicell from a “sell” rating to a “hold” rating in a research note on Wednesday, June 29th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $36.71.

The company’s 50-day moving average is $37.19 and its 200 day moving average is $32.14. The stock has a market cap of $1.41 billion and a PE ratio of 98.68.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, July 28th. The company reported $0.38 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.32 by $0.06. The firm earned $175.60 million during the quarter, compared to the consensus estimate of $170.89 million. The business’s revenue was up 55.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.28 EPS. Equities research analysts anticipate that Omnicell Inc. will post $1.58 earnings per share for the current fiscal year.

In related news, VP Jorge R. Taborga sold 1,778 shares of Omnicell stock in a transaction on Friday, August 19th. The stock was sold at an average price of $36.92, for a total value of $65,643.76. Following the completion of the sale, the vice president now owns 49,073 shares of the company’s stock, valued at $1,811,775.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Jorge R. Taborga sold 25,979 shares of Omnicell stock in a transaction on Monday, June 6th. The stock was sold at an average price of $33.00, for a total value of $857,307.00. Following the completion of the sale, the vice president now directly owns 50,734 shares of the company’s stock, valued at approximately $1,674,222. The disclosure for this sale can be found here.

Omnicell, Inc (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.